KWMG
TARO

King Wealth Management Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

King Wealth Management Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,500
Closed -$264K – 149
2019
Q3 		$264K Buy
+3,500
New +$284K 0.08% 113

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

King Wealth Management Group's TARO Position: Q4 2019 in Review

King Wealth Management Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2019, closing a stake of 3,500 shares — an estimated $264K sold.

King Wealth Management Group first reported a position in TARO in Q3 2019 and held it in 1 quarter. The position peaked at $264K in Q3 2019. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2019.

  • King Wealth Management Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2019 after selling out during the quarter.
  • King Wealth Management Group sold 3,500 Taro Pharmaceutical Industries Ltd. shares in Q4 2019, an estimated $264K.
  • King Wealth Management Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2019 and held it in 1 quarter.
  • King Wealth Management Group's Taro Pharmaceutical Industries Ltd. position peaked at $264K in Q3 2019.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2019.

Based on King Wealth Management Group's 13F filing for Q4 2019, filed 13 Feb 2020.